The annual International Trees and Trains exhibit has been a staple of the city of Lorain’s holiday festivities for the past 15 years. This year’s display, while still familiar, is a bit different, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

London’s Battersea Power Station is one of the most famous buildings in the world, largely thanks to it featuring on the cover of the Pink Floyd album Animals. After its decommissioning way back in ...

Last year, Wallace and Gromit were projected on to the Battersea Power Station’s 330-feet tall chimneys. The year before, work by David Hockney. This year, it could be yours. A U.K. competition ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

The city of La Mesa is hosting a series of free in-person and online events for residents to get directly involved in expanding the community’s urban tree canopy. The city is partnering with the ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Follow 24/7 Wall St. on Google By Joey Frenette Published ...

I’m usually opposed to both book destruction and the use of clichés but exceptions may have to be made for the new picture book from the Minnesota Historical Society, “How to Draw a Tree.” The book is ...

The president disputes reporting from The Wall Street Journal that he drew a picture for Jeffrey Epstein, but as a real estate mogul, he often sketched for charity. By Tyler Pager President Trump ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...